International |  Youth Programs | Newsroom | Store | Member Center

Search

Skip to Navigation
CADCA Building drug-free communities
Get Involved
  • Policy & Advocacy
  • Training & Events
  • Resources & Research
  • Interactive Media
  • About CADCA & The Institute
Home › Resources & Research ›
Subscribe to CADCA web feeds to stay informed of new content

Ecstasy Users Suffer Serotonin Transporter Deficit

  • Policy & Advocacy
  • Training & Events
  • Resources & Research
    • Community-Based Participatory Research
    • 2012 National Drug Control Strategy
    • Evaluation and Research
    • SoMe Wiki Home
      • Beneath Social Media
      • Metrics and Measures for Social Media
      • Social Engagement Tools
    • The Coalition Ideas Exchange
    • GIS Mapping
  • Interactive Media
  • About CADCA & The Institute

Filter by Series

  • Beyond the Basics (3)
  • Coalitions Newsletter (18)
  • Coalitions Online (1848)
  • Español (8)
  • Practical Theorist (8)
  • Primers (10)
  • Research & Evaluation Briefs (2)
  • Research into Action (30)
  • Strategizer (56)
  • Toolkit (4)

Search

By Title
By Issues
By Coalition resources
By Drug type

Get Online News Updates

Sign Up Now

Jul 08, 2010
Coalition resources: Data Analysis
Drug type: Ecstasy

Current users of ecstasy — those using about two tablets of the drug monthly — had lower levels of serotonin transporter (SERT) in the cerebral cortex of their brains, according to Canadian researchers who successfully replicated a smaller study from Johns Hopkins University.

Ecstasy use causes serotonin release; researchers said it was unclear whether the lower SERT levels indicated damage to serotonin nerve cells themselves.

"Most of the ecstasy users of our study complained that the first dose is always the best, but then the effects begin to decline and higher doses are needed," said Stephen Kish, a researcher at the Centre for Addiction and Mental Health in Toronto. "The need for higher doses, possibly caused by low SERT, could well increase the risk of harm caused by this stimulant drug."

The latest study found that SERT levels were only depressed in the cerebral cortex, not throughout the brain. The findings were published online in the journal Brain.
 

Community Anti-Drug Coalitions of America
625 Slaters Lane Suite 300 Alexandria, VA 22314
Tel 1-800-54-CADCA  Fax 703-706-0565

Join CADCA
Donate
Thanks to Our Sponsors
All content © copyright 2009 All rights reserved. Privacy Policy | Contact Us | Careers | Sitemap